WebDec 9, 2024 · Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease. With our lead program in Phase 3 clinical development, Atara is the most advanced ... WebSep 14, 2024 · Atara is applying this one platform to create a robust pipeline including: tab-cel ® (tabelecleucel) in Phase 3 development for Epstein-Barr virus-driven post …

Atara Biotherapeutics (ATRA) 资讯 - Moomoo

WebApr 13, 2024 · A phase 1 clinical trial by the California-based immunotherapy company Atara Biotherapeutics confirms latent Epstein-Barr (EBV) infections are viable targets for … WebATA188, Atara’s investigational off-the-shelf T-cell candidate, has the potential to target EBV-infected B cells and plasma cells in the central nervous system that may catalyze … hvac cleaning scottsdale

Job Posting - Research Associate Sr. Research Associate

WebATARA - Home Page. Most teens make the transition to adulthood with a sense of anticipation and opportunity. Some Do Not. Young adults who age out of the social … WebDec 7, 2024 · Atara’s allogeneic EBV CAR T-cell platform is designed to improve upon current CAR T therapy; ATA3219 leverages this novel platform and incorporates 1XX CAR signaling technologies Preclinical findings with ATA3219 show potent antitumor activity both in vitro and in vivo, with long-term persistence and no evidence of allocytoxicity in vivo WebJul 1, 2024 · Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases ... hvac cleaning minneapolis